Cancer Biology Market Analysis and Reports | USA Conference Series

Market Analysis - Cancer Biology 2018

Market Analysis

 

Cancer Biology & Drug Delivery Market Overview:

Global Oncology/Cancer Biology Market is relied upon to collect $111.9 billion by 2020, enlisting a CAGR of 7.1% amid the conjecture time frame 2014 to 2020. Late advance in organic treatments has enlarged the size of restorative focuses for treatment of malignancy with the distinguishing proof of tumor cell particular qualities. Immunotherapies/biologics are developing as potential treatments to locate the changeless cure for different growth sorts. Among different biologics, drugs in view of monoclonal antibodies (mAbs) have increased critical consideration as of late because of their high adequacy.

Worldwide tumor drugs showcase represented $78,238.9 million of every 2015. The growth drugs advertise is driven by the developing predominance of different sorts of tumor, expanding interest of organic and focused on sedate treatments, persistent patent expiry of key disease drugs and the rising effect of biosimilars. In any case, the high cost of medication improvement, the danger of disappointment and the antagonistic impacts of disease tranquilize treatment, especially chemotherapy, blocks the market development. Created countries have executed strict directions for the outline and advancement of growth drugs. USFDA and European Union have embraced noteworthy activities to fuel the development of the growth drugs showcase by giving pre-advertise endorsement to potential medications under clinical advancement. Asia-Pacific and LAMEA are promising districts for leading clinical trials due a vast populace base and the minimal effort of clinical trials when contrasted with North America and Europe. In any case, headway of growth medicate look into inferable from natural/directed treatments and customized meds hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating disease drugs.

Key Findings of Oncology Drugs Market:

Immunotherapy/natural medications portion anticipated that would develop at a twofold digit CAGR amid the figure time frame and would develop at the quickest rate. Blood malignancy is the real income producing fragment in the worldwide oncology tranquilize application showcase be that as it may, lung tumor section is relied upon to become quickest among all. At present, North America gathers a noteworthy offer in the oncology drugs advertise, as far as market measure. Asia Pacific oncology medicate showcase is overwhelmed by China and Japan, together adding to ~60% of the provincial market income in 2014. A lion's share of the oncology medicate makers have received joint effort and securing as key formative methodologies to accomplish a focused edge. In addition, organizations are likewise shaping vital partnerships to quicken the procedure of clinical trials. These procedures have turned out to be successful in helping key market players hold their driving positions in the worldwide oncology drugs advertise. Enter organizations profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson and Johnson, Merck and Co., Eli Lilly and Co., Amgen Inc., Pfizer and GlaxoSmithKline.

Market Segment Review:

The focused structure of the worldwide malignancy drugs advertise is broke down utilizing Porter's Five Forces Model. As indicated by Porter's investigation, the haggling energy of purchasers is low due high cost of medications, lesser information about the items/drugs. Nonetheless, the dealing energy of providers tends to direct inferable from their lower fixation and prerequisite of higher capital venture. Growth drugs are for the most part secured with IPR rights in this manner, prompts increment in the boundaries for new participants.

Worldwide tumor drugs showcase by helpful modalities is portioned into chemotherapy, Targeted treatment, Immunotherapy, Hormonal treatment and others. Immunotherapy overwhelms the worldwide market for tumor medicates because of its high adequacy and less reactions. Monoclonal antibodies, for example, trastuzumab, bevacizumab and rituximab are potential immunotherapeutic specialists that have accomplished generous deals. The growth immunotherapy showcase is essentially determined by tremendous research speculations from multinational organizations alongside inquire about coordinated efforts for the improvement of malignancy immunotherapeutics. In the course of recent years, directed malignancy treatments have increased noteworthy consideration because of their tumor cell particular activity in shielding solid cells from the lethal impacts of growth drugs.

Worldwide growth drugs showcase by malignancy sort is portioned into Blood tumor, Breast disease, gastrointestinal tract growth, Prostate tumor, Lung Cancer, Skin Cancer and other malignancy. Among these distinctive growth sorts, blood disease was the biggest income creating section in 2015. The development of blood disease fragment is significantly because of the high cost of the medications used to treat blood growth. The pervasiveness of blood growth is less in created countries, be that as it may, the determination rate is over 90% and practically every individual determined to have blood malignancy looks for finish treatment for the cure of blood tumor. Because of the high expendable wages of purchasers in created countries, costly medication treatment of blood malignancy is reasonable in these districts. Lion's share of the as of late advanced biologics (drugs in view of monoclonal antibodies) demonstrated a noteworthy cure for blood tumor; consequently, use rate of these medication is high, in spite of their high cost.

Geographic Review:

Geologically, the Global disease drugs advertise fragments into North America, Europe, Asia-Pacific and LAMEA. North America commands the market for disease sedates as the district houses organizations occupied with the advancement of tumor drugs. Moreover, the dispensable livelihoods of customers and medical coverage cover forever undermining sicknesses in North America are high which expands the reasonableness of disease treatment. As of late, US Food and Drug Administration (USFDA) has taken activities to help the development of tumor drugs advertise by giving pre-showcase endorsement to the medications, which are in the clinical stage; in this way, quickening the clinical advancement.

Countless in North America demonstrate generous interest in R&D from multinational organizations and also investigate associations. Europe is the second biggest market for malignancy sedates and is relied upon to develop at a CAGR of 6.8% amid the investigation time frame. In North America and Europe, a dominant part of the multinational players have concentrated on the improvement of biologics or immunotherapeutic attributable to its high viability and target particular activity. The exploration for tumor medicates in Asia-Pacific and LAMEA is rising with the concentration towards the advancement of biosimilars. The commonness of different growth sorts is high in creating nations which render these areas as promising areas to lead clinical trials. In addition, the cost of clinical research is low in these districts because of the accessibility of an enormous populace base and ideal government approaches.

Japan Oncology/Cancer Drugs Market Review:

Japan has largest share to the total Asia Pacific cancer drug market due to the high prevalence of cancer in Japanese population. Lung cancer is the major cause of death in Japanese population. The total healthcare expenditure of japan was $495 billion in 2013. 

Several new drugs are now approved in Japan, including Afinitor, Avastin, Jevtana, Sutent and Zytiga, which could trigger a growth of cancer drug market and a shift in the treatment paradigm in the foreseen future.

Access to new drugs might be delayed in Japan due to strict regulatory processes in Japan. Pharmaceutical and Medical Devices Agency (PMDA) and Ministry of Health, Labor and Welfare (MHLW), are the regulatory agencies in Japan. Jevtana (Cabazitaxel acetonate) and MabCampath (Alemtuzumab), by Sanofi, are recently approved cancer drugs in Japan.

Japanese government health insurance is the most generous in Asia and offers the highest rates of reimbursement. The government offers coverage for approved treatments, including treatments for cancer, to all citizens. The treatments are eligible for coverage as long as they are approved by Japan’s MHLW.

          Japan oncology/cancer drugs market by therapeutic modalities, 2020

Competitive Review:

The key players profiled in this report include Amgen Inc., Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co., Roche diagnostics, Novartis AG, Pfizer, Merck & Co., Sanofi, and Celgene Corporation. Roche, Novartis and Celgene are the top three players in Global cancer drugs market with a wide of cancer product portfolio. The three companies contribute to ~60% of the total market share. The immunotherapeutics developed by Roche namely Rituxan, Avastin and Herceptin achieved blockbuster sales in 2013. A majority of the cancer drug manufacturers have adopted collaboration, approval and acquisition as their key developmental strategies to achieve a competitive edge. Moreover, companies are forming strategic alliances to accelerate their clinical developments. These strategies have proved to be effective in helping key players retain their leading positions in the global market.

ONCOLOGY DRUGS MARKET KEY BENEFITS

  • The report provides the quantitative analysis of the current trends, size and estimations for the forecast period 2013-2020 that assists in identifying the prevailing opportunities to capitalize on

  • The report helps in understanding the strategies adopted by various companies for consolidating their positions in the industry.

  • The report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs market

  • Demand and supply conditions of cancer drugs across all geographic regions are comprehensively analyzed

  • Competitive intelligence (of leading manufacturers) helps in understanding the competitive market scenario and opportunities across the geographies

  • SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies

ONCOLOGY/CANCER DRUGS MARKET SEGMENTATION

The Oncology drugs market is segmented by the therapeutic modalities, cancer types and geography.

BY THERAPEUTIC MODALITIES

  • Chemotherapy

  • Targeted Therapy

  • Immunotherapy (Biologic Therapy)

  • Hormonal Therapy

  • Others

BY CANCER TYPES

  • Blood Cancer

  • Breast Cancer

  • Gastrointestinal Cancer

  • Prostate Cancer

  • Respiratory/Lung Cancer

  • Skin Cancer

  • Other Cancers

 

 

BY GEOGRAPHY

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Others
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • Others
  • LAMEA
    • GCC (Gulf Corporation Council)
    • Others

Importance and Scope:

The Importance of Cancer 2018 is to redesign, clinically critical gathering of people concerning the confirmation supporting ebb and flow Advances in finding and treatment in the field of Cancer Research. Specialists and researchers over the globe will trade perspectives and ideas. Understudies/Scholars from various colleges assemble and improve their insight. Demonstrative and Pharmaceutical firms will show their novel items and administrations, which permit them to build up their business universally. Cancer 2018 is a universal stage for showing research, exchanging ideas concerning it and along these lines, contributes towards spreading data in research strategies, in analysis and counteractive action of Caner and Related sickness and so forth for the upside of every youthful specialist, Pharmaceutical firms, researchers and the scholarly world. Cancer 2018 is wherever the more drawn out term of show new diagnostics strategies and Instruments utilized for treatment and finding and novel medication. This occasion brings along senior brand advertisers and office administrators to investigate advancing and publicizing openings on Pharmaceutical partnerships.

Why Los Angeles, USA?

Los Angeles officially the City of Los Angeles and often known by its initials L.A., is the cultural, financial, and commercial center of Southern California. With a U.S. Census-estimated 2016 population of 3,976,322 it is the second most populous city in the United States (after New York City) and the most populous city in the state of California. There are three public universities located within the city limits: California State University, Los Angeles (CSULA), California State University, Northridge (CSUN) and University of California, Los Angeles (UCLA). There are 841 museums and art galleries in Los Angeles County. In fact, Los Angeles has more museums per capita than any other city in the world. Some of the notable museums are the Los Angeles County Museum of Art (the largest art museum in the Western United States.

Conference Highlights:

Tracks 1: Cancer

Track 2: Cancer Biology

Track 3: Organ Specific Cancer

Track 4: Drug Delivery

Track 5: Hematology-Oncology

Track 6: Cancer Therapy

Track 7: Oncogenomics

Track 8: Cancer Imaging

Track 9: Cancer Biomarkers

Track 10: Cancer Pharmacology

Track 11: Gynecologic Oncology

Track 12: Cancer Stem Cells

Track 13: Molecular Cancer

Track 14: DNA Repair and Cancer

Track 15: Immunotherapy

Track 16: Cancer Treatments and Vaccines

Track 17: Chemotherapy

Track 18: Cancer Epidemiology

Track 19: Global Market for Cancer Treatments

Track 20: Cancer Treatments and Market Dynamics

Why to attend Cancer Biology & Drug Delivery?

Team Cancer Biology & Drug Delivery aims to deliver a perfect platform to the scientific and industry personnel to share their knowledge and expertise. It gives opportunity to conduct demonstrations, distribute information, meet with current and potential speakers/Delegates all around the world which are working on the very emerging field of Cancer Biology & Drug Delivery, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Cancer Biology & Drug Delivery fields are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://cancerbiology.conferenceseries.com/

Target Audience:

For Cancer Biology & Drug Delivery mainly the target audiences are Cancer Biology & Drug Delivery Scientists, Students, Researchers, Faculty, Cancer Biology & Drug Delivery Associations and Societies, Medical Colleges, Oncologist, Pathologist, Haematologist and Neurologist.

Hospitals related to Cancer in California:

  • California Northstate University College of Medicine
  • Charles R. Drew University of Medicine and Science
  • Keck School of Medicine of University of Southern California
  • Loma Linda University School of Medicine
  • Stanford University School of Medicine
  • University of California, Davis School of Medicine
  • University of California, Irvine School of Medicine
  • David Geffen School of Medicine at UCLA
  • University of California, Riverside School of Medicine
  • University of California, San Diego School of Medicine
  • Hospitals related to Cancer in USA:

There are 902 Hospitals working on Cancer in USA few of them are listed below:

  • Memorial Sloan Kettering (MSK) Cancer Center, New York City

  • University of Texas M.D. Anderson Cancer Center, Houston

  • Mayo Clinic, Rochester, Minnesota

  • Dana-Farber/Brigham and Women's Cancer Center, Boston

  • Johns Hopkins Hospital, Baltimore, Maryland

  • University of Washington Medical Center, Seattle

  • Massachusetts General Hospital, Boston

  • UCSF Medical Center, San Francisco

  • Stanford Hospital and Clinics, Stanford, California

  • Hospitals of the University of Pennsylvania–Penn Presbyterian, Philadelphia

  • City of Hope, Los Angeles

  • Cleveland Clinic

  • New York–Presbyterian University Hospital of Columbia and Cornell, New York City

  • University of Colorado Hospital, Denver

  • Moffitt Cancer Center, Tampa, Florida

  • Northwestern Memorial Hospital, Chicago

  • Seidman Cancer Center at UH Case Medical, Cleveland

  • Fox Chase Cancer Center, Philadelphia

There are 9368 Hospitals working on Cancer Worldwide few of them are listed below:

  • University of Texas MD Anderson Cancer Center (Houston)

  • University of Texas MD Anderson Cancer Center (Houston)

  • Memorial Sloan-Kettering Cancer Center (New York) 

  • Memorial Sloan-Kettering Cancer Center (New York)

  • Johns Hopkins Hospital (Baltimore) 

  • Mayo Clinic (Rochester, Minn.)

  • Dana-Farber/Brigham and Women's Cancer Center (Boston)

  • Duke University Medical Center (Durham, N.C.) 

  • Seattle Cancer Care Alliance/University of Washington Medical Center (Seattle)

  • University of Chicago Hospitals

  • Johns Hopkins Hospital (Baltimore) and UCLA Medical Center (Los Angeles)

  • Massachusetts General Hospital (Boston)

  • UCLA Medical Center (Los Angeles)

  • Massachusetts General Hospital (Boston)

  • Roswell Park Cancer Institute (Buffalo, N.Y.) 

  • UCSF Medical Center (San Francisco)

  • Top universities/ College related to Cancer in Philadelphia:

  • Abramson Family Cancer Research Institute

  • Wistar Institute: Conejo-Garcia Jose R MD

  • Fox Chase Cancer Center

  • Cancer Treatment Centers of America at Eastern Regional Medical Center

  • Thomas Jefferson University

  • Abramson Cancer Center Hospital University of Pennsylvania (HUP)

  • Kimmel Cancer Center

  • University of Pennsylvania Hematology/Oncology Fellowship

  • Fels Institute

  • Abramson Cancer Center: Feldman Arthur M MD

  • Top universities/ College related to Cancer in USA:

There are about 60 universities/ Colleges working on Cancer in USA few of them are listed below:

  • Massachusetts Institute of Technology

  • University of California at Los Angeles

  • Johns Hopkins University

  • Texas A & M University

  • Princeton University

  • California Institute of Technology – Caltech

  • Yale University

  • Cornell University

  • Georgia University of Technology

  • Emory University

  • Stanford University

  • Northwestern University

  • University of Miami

  • Top universities/ College related to Cancer in Worldwide:

There are 2443 universities/ Colleges working on Cancer Worldwide few of them are listed below:

  • Harvard University

  • University of Cambridge

  • University of Oxford

  • Massachusetts Institute of Technology

  • Johns Hopkins University

  • Stanford University

  • University of California, San Francisco (UCSF)

  • Yale University

  • Karolinska Instituet

  • University of California, Los Angeles (UCLA)

  • The University of Sydney

  • The University of Melbourne

  • King’s College London

  • University of Michigan

  • McGill University

  • The University of Edinburgh

  • Kyoto University

  • Hong Kong University of Science and Technology

  • University of Tsukuba

  • Major Associations/ Societies related to Cancer

  • American Cancer Society

  • Cancer Research Institute

  • Children’s Cancer research Fund

  • The Lance Armstrong Foundation

  • Vietnam Cancer Charities Fund

  • Cancer Survivor’s Fund

  • Acoustic Neuroma Association

  • Acoustic Neuroma Association of Australia

  • Acoustic Neuroma Association of Canada

  • American Association for Cancer Research

  • American Bone Marrow Donor Registry

  • American Brain Tumor Association

  • Companies related to Cancer Worldwide:

  • Abbott Laboratories

  • Abbott Nutrition

  • Abbvie And Biogen

  • Acadia Pharmaceuticals

  • Acorda Therapeutics

  • Actelion Pharmaceuticals

  • Acura Pharmaceuticals

  • Aegerion Pharmaceuticals

  • Akrimax Pharmaceuticals

  • Alcon Laboratories

  • Alexion Pharmaceuticals

  • Amneal Pharmaceuticals

  • Amphastar Pharmaceuticals

  • Ani Pharmaceuticals

  • Aptalis Pharmaceutical Technologies

  • Aqua Pharmaceuticals

  • Atnahs Pharma

  • Aytu Bioscience